• Je něco špatně v tomto záznamu ?

Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene

L. Krausova, L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, P. Pavek

. 2011 ; 82 (11) : 1771-1780. [pub] 20110906

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12022121

Metformin is widely used in the treatment of type-2 diabetes. The pleotropic effects of metformin on glucose and lipid metabolism have been proposed to be mediated by the activation of AMP-activated protein kinase (AMPK) and the subsequent up-regulation of small heterodimer partner (SHP). SHP suppresses the functions of several nuclear receptors involved in the regulation of hepatic metabolism, including pregnane X receptor (PXR), which is referred to as a "master regulator" of drug/xenobiotic metabolism. In this study, we hypothesize that metformin suppresses the expression of CYP3A4, a main detoxification enzyme and a target gene of PXR, due to SHP up-regulation. We employed various gene reporter assays in cell lines and qRT-PCR in human hepatocytes and in Pxr(-/-) mice. We show that metformin dramatically suppresses PXR-mediated expression of CYP3A4 in hepatocytes. Consistently, metformin significantly suppressed the up-regulation of Cyp3a11 mRNA in the liver and intestine of wild-type mice, but not in Pxr(-/-) mice. A mechanistic investigation of the phenomenon showed that metformin does not significantly up-regulate SHP in human hepatocytes. We further demonstrate that AMPK activation is not involved in this process. We show that metformin disrupts PXR's interaction with steroid receptor coactivator-1 (SRC1) in a two-hybrid assay independently of the PXR ligand binding pocket. Metformin also inhibited vitamin D receptor-, glucocorticoid receptor- and constitutive androstane receptor (CAR)-mediated induction of CYP3A4 mRNA in human hepatocytes. We show, therefore, a suppressive effect of metformin on PXR and other ligand-activated nuclear receptors in transactivation of the main detoxification enzyme CYP3A4 in human hepatocytes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12022121
003      
CZ-PrNML
005      
20151013150322.0
007      
ta
008      
120806s2011 xxk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.bcp.2011.08.023 $2 doi
035    __
$a (PubMed)21920351
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Krausová, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic $7 xx0122166
245    10
$a Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene / $c L. Krausova, L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, P. Pavek
520    9_
$a Metformin is widely used in the treatment of type-2 diabetes. The pleotropic effects of metformin on glucose and lipid metabolism have been proposed to be mediated by the activation of AMP-activated protein kinase (AMPK) and the subsequent up-regulation of small heterodimer partner (SHP). SHP suppresses the functions of several nuclear receptors involved in the regulation of hepatic metabolism, including pregnane X receptor (PXR), which is referred to as a "master regulator" of drug/xenobiotic metabolism. In this study, we hypothesize that metformin suppresses the expression of CYP3A4, a main detoxification enzyme and a target gene of PXR, due to SHP up-regulation. We employed various gene reporter assays in cell lines and qRT-PCR in human hepatocytes and in Pxr(-/-) mice. We show that metformin dramatically suppresses PXR-mediated expression of CYP3A4 in hepatocytes. Consistently, metformin significantly suppressed the up-regulation of Cyp3a11 mRNA in the liver and intestine of wild-type mice, but not in Pxr(-/-) mice. A mechanistic investigation of the phenomenon showed that metformin does not significantly up-regulate SHP in human hepatocytes. We further demonstrate that AMPK activation is not involved in this process. We show that metformin disrupts PXR's interaction with steroid receptor coactivator-1 (SRC1) in a two-hybrid assay independently of the PXR ligand binding pocket. Metformin also inhibited vitamin D receptor-, glucocorticoid receptor- and constitutive androstane receptor (CAR)-mediated induction of CYP3A4 mRNA in human hepatocytes. We show, therefore, a suppressive effect of metformin on PXR and other ligand-activated nuclear receptors in transactivation of the main detoxification enzyme CYP3A4 in human hepatocytes.
650    _2
$a proteinkinasy aktivované AMP $x fyziologie $7 D055372
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
650    _2
$a reportérové geny $7 D017930
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x farmakologie $7 D007004
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a metformin $x farmakologie $7 D008687
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a koaktivátory jaderných receptorů $x metabolismus $7 D056918
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    _2
$a receptory kalcitriolu $x fyziologie $7 D018167
650    _2
$a receptory cytoplazmatické a nukleární $x metabolismus $x fyziologie $7 D018160
650    _2
$a receptory glukokortikoidů $x fyziologie $7 D011965
650    _2
$a steroidní receptory $x genetika $x fyziologie $7 D011987
650    _2
$a polohový reflex $x účinky léků $7 D057897
650    _2
$a signální transdukce $7 D015398
650    _2
$a aktivace transkripce $7 D015533
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stejskalová, Lucie $7 xx0142114 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic
700    1_
$a Wang, Hongwei $u Albert Einstein Cancer Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Chanin 302D-1 Bronx, NY 1046, United States
700    1_
$a Vrzal, Radim $7 xx0118949 $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 11, Olomouc, Czech Republic
700    1_
$a Dvořák, Zdeněk, $d 1974- $7 xx0118950 $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 11, Olomouc, Czech Republic
700    1_
$a Mani, Sridhar $u Albert Einstein Cancer Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Chanin 302D-1 Bronx, NY 1046, United States
700    1_
$a Pávek, Petr $7 xx0093070 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic
773    0_
$w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 82, č. 11 (2011), s. 1771-1780
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21920351 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120806 $b ABA008
991    __
$a 20151013150511 $b ABA008
999    __
$a ok $b bmc $g 944034 $s 779418
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 82 $c 11 $d 1771-1780 $e 20110906 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
LZP    __
$b NLK111 $a Pubmed-20120806/12/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...